JP Morgan 2023 – Lisa Yañez
In our penultimate JP Morgan 2023 interview, pharmaphorum editor-in-chief Jonah Comstock caught up with Lisa Yañez, CEO of Aerami Therapeutics, at the Fairmont Hotel. Aerami is working on a drug-device combination to expand treatment options for the rare disease pulmonary arterial hypertension: inhaled imatinib combines a proven inhaler with a promising drug.
Yañez describes how the approach creates new options for these chronically ill patients. She also discusses how the current financial climate is pushing companies to focus on their strongest core competency, and how her company listens to the voice of the patient.
Tune in to learn more about this Durham, North Carolina-based pharma company which just announced an expansion of its inhaled imatinib programme.